1. Home
  2. RCKT vs VPG Comparison

RCKT vs VPG Comparison

Compare RCKT & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • VPG
  • Stock Information
  • Founded
  • RCKT 1999
  • VPG 2009
  • Country
  • RCKT United States
  • VPG United States
  • Employees
  • RCKT N/A
  • VPG N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • VPG Electrical Products
  • Sector
  • RCKT Health Care
  • VPG Technology
  • Exchange
  • RCKT Nasdaq
  • VPG Nasdaq
  • Market Cap
  • RCKT 328.6M
  • VPG 340.4M
  • IPO Year
  • RCKT N/A
  • VPG N/A
  • Fundamental
  • Price
  • RCKT $3.28
  • VPG $28.45
  • Analyst Decision
  • RCKT Buy
  • VPG
  • Analyst Count
  • RCKT 13
  • VPG 0
  • Target Price
  • RCKT $12.96
  • VPG N/A
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • VPG 103.9K
  • Earning Date
  • RCKT 08-07-2025
  • VPG 08-05-2025
  • Dividend Yield
  • RCKT N/A
  • VPG N/A
  • EPS Growth
  • RCKT N/A
  • VPG N/A
  • EPS
  • RCKT N/A
  • VPG N/A
  • Revenue
  • RCKT N/A
  • VPG $295,282,000.00
  • Revenue This Year
  • RCKT N/A
  • VPG N/A
  • Revenue Next Year
  • RCKT $108.43
  • VPG $5.48
  • P/E Ratio
  • RCKT N/A
  • VPG N/A
  • Revenue Growth
  • RCKT N/A
  • VPG N/A
  • 52 Week Low
  • RCKT $2.19
  • VPG $18.57
  • 52 Week High
  • RCKT $22.01
  • VPG $30.11
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • VPG 54.91
  • Support Level
  • RCKT $2.88
  • VPG $28.22
  • Resistance Level
  • RCKT $3.74
  • VPG $29.81
  • Average True Range (ATR)
  • RCKT 0.27
  • VPG 0.87
  • MACD
  • RCKT 0.02
  • VPG 0.15
  • Stochastic Oscillator
  • RCKT 35.43
  • VPG 62.29

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

Share on Social Networks: